TVTX Travere Therapeutics Inc

USD 18.10 +0.53 ( +3.02)%
Icon

Travere Therapeutics Inc (TVTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 18.10

+0.53 (+3.02)%

USD 1.37B

1.33M

USD 19.27(+6.46%)

USD 22.50 (+24.31%)

Icon

TVTX

Travere Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 18.10
+0.53 ( +3.02)%

Travere Therapeutics Inc (TVTX) Stock Forecast

Show ratings and price targets of :
USD 19.27
(+6.46%)

Based on the Travere Therapeutics Inc stock forecast from 14 analysts, the average analyst target price for Travere Therapeutics Inc is USD 19.27 over the next 12 months. Travere Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Travere Therapeutics Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Travere Therapeutics Inc’s stock price was USD 18.10. Travere Therapeutics Inc’s stock price has changed by +1.23% over the past week, +18.84% over the past month and +159.68% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...